Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present vTv Therapeutics Inc (NASDAQ: VTVT).

Full DD Report for VTVT

You must become a subscriber to view this report.


Recent News from (NASDAQ: VTVT)

vTv Therapeutics beats by $0.06, misses on revenue
vTv Therapeutics (NASDAQ: VTVT ): Q1 EPS of -$0.30 beats by $0.06 . More news on: vTv Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 15 2018 16:46
vTv Therapeutics Reports 2018 First Quarter Financial and Operational Results and Recent Highlights
vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial and operational results for the first quarter that ended March 31, 2018. “We continue to make progress on all of our major programs,” said Steve Holcombe, chief executive officer, vTv Therapeutics. “While...
Source: Business Wire
Date: May, 15 2018 16:30
Oryzon Genomics commences mid-stage study of Alzheimer's candidate
Spanish biotech Oryzon Genomics announces that enrollment is underway in a Phase 2b clinical trial assessing ORY-2001 in patients with mild-to-moderate Alzheimer's disease (AD). More news on: vTv Therapeutics, Biogen Inc., Tonix Pharmaceuticals Holding Corp., Healthcare stocks news, ...
Source: SeekingAlpha
Date: May, 14 2018 12:27
Keeping It Simple On The Short Side
Welcome to Editor's Notes! I aim to sort through the ideas we publish each day and highlight a few that may be of interest to readers, along with comments that may add a helpful gloss. If you have thoughts, comment below or send me a direct message and let me know what you think. Your fe...
Source: SeekingAlpha
Date: May, 11 2018 13:20
Today's Research Reports on Stocks to Watch: vTv Therapeutics and ARCA Biopharma
NEW YORK, NY / ACCESSWIRE / May 11, 2018 / vTv Therapeutics and ARCA biopharma were both soaring in Thursday's trading session. Both had news as catalysts to drive shares higher with vTv Therapeutics announcing that the company will pre-specify new subgroup with the FDA and report phase 3 p...
Source: ACCESSWIRE IA
Date: May, 11 2018 08:20
Midday Gainers / Losers (05/10/2018)
Gainers: ARMO +67% . HEAR +63% . KOSS +34% . VTVT +24% . DEPO +22% . PBH +22% . MRAM +20% . SLDB +18% . MCEP +18% . NCTY +18% . More news on: ARMO BioSciences, Inc., Turtle Beach Corporation, Koss Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 10 2018 12:45
Your Daily Pharma Scoop: AcelRx Resubmits, MannKind Finds New Realms, VTVT Up On Mixed Data
Analysis focus: ACRX If you recall your AcelRx (NASDAQ: ACRX ), it got a CRL for DSUVIA lasy year citing safety concerns and drug administration issues. The exact things the FDA said, as reported by the company, were: “The two primary recommendations within the CRL are: first, while...
Source: SeekingAlpha
Date: May, 10 2018 10:00
VTv Therapeutics +19.9% on statistics positive in azeliragon study
VTv Therapeutics (NASDAQ: VTVT ) is up 19.9% postmarket after saying that though its Phase 3 STEADFAST study of azeliragon in patients with mild Alzheimer's disease didn't meet co-primary endpoints, it's identified a sub-population that showed statistically significant benefits . More n...
Source: SeekingAlpha
Date: May, 09 2018 19:30
After Hours Gainers / Losers (05/09/2018)
Top gainers:   HEAR   +52.5% .  VTVT +26.5% . MRAM   +6.4% . INFN +6.2% . DCIX   +5.5% . More news on: Turtle Beach Corporation, vTv Therapeutics, Everspin Technologies, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: May, 09 2018 17:36
vTv Therapeutics Announces Company will Pre-specify New Subgroup with the FDA and Report Phase 3 Part B Results in June
Subgroup of Mild Alzheimer’s Patients in Part A of Phase 3 STEADFAST Study Demonstrated Positive Benefit vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that based on post-hoc analyses of the data from Part A of the Company’s Phase 3 STEADFAST study of the investig...
Source: Business Wire
Date: May, 09 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-171.601.811.951.592,937,666
2017-02-155.545.465.545.407,733
2017-02-145.545.595.605.5022,163
2017-02-135.475.505.525.3911,950
2017-02-105.415.495.495.414,660

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-176,27035,42417.6999Cover
2018-08-168,43519,70242.8129Short
2018-08-1514,33727,56852.0059Short
2018-08-143,2598,83636.8832Short
2018-08-1340010,0593.9765Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VTVT.


About vTv Therapeutics Inc (NASDAQ: VTVT)

Logo for vTv Therapeutics Inc (NASDAQ: VTVT)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $18,029,452 - 05/11/2018
  • Issue and Outstanding: 9,693,254 - 02/24/2017

 


Recent Filings from (NASDAQ: VTVT)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 09 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 06 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 19 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 16 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018

 

 


Daily Technical Chart for (NASDAQ: VTVT)

Daily Technical Chart for (NASDAQ: VTVT)


Stay tuned for daily updates and more on (NASDAQ: VTVT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: VTVT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VTVT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of VTVT and does not buy, sell, or trade any shares of VTVT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/